|
1
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mayr FB, Yende S and Angus DC:
Epidemiology of severe sepsis. Virulence. 5:4–11. 2014. View Article : Google Scholar :
|
|
3
|
Plevin R and Callcut R: Update in sepsis
guidelines: What is really new? Trauma Surg Acute Care Open.
2:e0000882017. View Article : Google Scholar
|
|
4
|
Cheng B, Hoeft AH, Book M, Shu Q and
Pastores SM: Sepsis: Pathogenesis, biomarkers, and treatment.
Biomed Res Int. 2015:846935. 2015. View Article : Google Scholar
|
|
5
|
Maloney PJ: Sepsis and septic shock. Emerg
Med Clin North Am. 31:583–600. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adhikari NK, Fowler RA, Bhagwanjee S and
Rubenfeld GD: Critical care and the global burden of critical
illness in adults. Lancet. 376:1339–1346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kakihana Y, Ito T, Nakahara M, Yamaguchi K
and Yasuda T: Sepsis-induced myocardial dysfunction:
Pathophysiology and management. J Intensive Care. 4:222016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu YC, Yu MM, Shou ST and Chai YF:
Sepsis-induced cardiomyopathy: mechanisms and treatments. Front
Immunol. 8:10212017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ho J, Yu J, Wong SH, Zhang L, Liu X, Wong
WT, Leung CC, Choi G, Wang MH, Gin T, et al: Autophagy in sepsis:
Degradation into exhaustion. Autophagy. 12:1073–1082. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Y, Shang P and Li D: Luteolin: A
flavonoid that has multiple cardio-protective effects and its
molecular mechanisms. Front Pharmacol. 8:6922017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lopez-Lazaro M: Distribution and
biological activities of the flavonoid luteolin. Mini Rev Med Chem.
9:31–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seelinger G, Merfort I and Schempp CM:
Anti-oxidant, anti-inflammatory and anti-allergic activities of
luteolin. Planta Med. 74:1667–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu T, Li D and Jiang D: Targeting cell
signaling and apoptotic pathways by luteolin: Cardioprotective role
in rat cardiomyocytes following ischemia/reperfusion. Nutrients.
4:2008–2019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi L, Pan H, Li D, Fang F, Chen D and Sun
H: Luteolin improves contractile function and attenuates apoptosis
following ischemia-reperfusion in adult rat cardiomyocytes. Eur J
Pharmacol. 668:201–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abu-Elsaad N and El-Karef A: The falconoid
luteolin mitigates the myocardial inflammatory response induced by
high-carbohydrate/ high-fat diet in wistar rats. Inflammation.
41:221–231. 2018. View Article : Google Scholar
|
|
16
|
Nakayama A, Morita H, Nakao T, Yamaguchi
T, Sumida T, Ikeda Y, Kumagai H, Motozawa Y, Takahashi T, Imaizumi
A, et al: A food-derived flavonoid luteolin protects against
angiotensin II-induced cardiac remodeling. PLoS One.
10:e01371062015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parzych KR and Klionsky DJ: An overview of
autophagy: Morphology, mechanism, and regulation. Antioxid Redox
Signal. 20:460–473. 2014. View Article : Google Scholar :
|
|
18
|
Mialet-Perez J and Vindis C: Autophagy in
health and disease: Focus on the cardiovascular system. Essays
Biochem. 61:721–732. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morel E, Mehrpour M, Botti J, Dupont N,
Hamai A, Nascimbeni AC and Codogno P: Autophagy: A druggable
process. Annu Rev Pharmacol Toxicol. 57:375–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi W, Watanabe E, Fujimura L,
Watanabe-Takano H, Yoshidome H, Swanson PE, Tokuhisa T, Oda S and
Hatano M: Kinetics and protective role of autophagy in a mouse
cecal ligation and puncture-induced sepsis. Crit Care. 17:R1602013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren C, Zhang H, Wu TT and Yao YM:
Autophagy: A potential therapeutic target for reversing
sepsis-induced immunosuppression. Front Immunol. 8:18322017.
View Article : Google Scholar
|
|
22
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Escobar DA, Botero-Quintero AM, Kautza BC,
Luciano J, Loughran P, Darwiche S, Rosengart MR, Zuckerbraun BS and
Gomez H: Adenosine monophosphate-activated protein kinase
activation protects against sepsis-induced organ injury and
inflammation. J Surg Res. 194:262–272. 2015. View Article : Google Scholar
|
|
24
|
Li P, Chen XR, Xu F, Liu C, Li C, Liu H,
Wang H, Sun W, Sheng YH and Kong XQ: Alamandine attenuates
sepsis-associated cardiac dysfunction via inhibiting MAPKs
signaling pathways. Life Sci. 206:106–116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu J, Man W, Shen M, Zhang M, Lin J, Wang
T, Duan Y, Li C, Zhang R, Gao E, et al: Luteolin alleviates
post-infarction cardiac dysfunction by up-regulating autophagy
through Mst1 inhibition. J Cell Mol Med. 20:147–156. 2016.
View Article : Google Scholar
|
|
26
|
Wu B, Lin J, Luo J, Han D, Fan M, Guo T,
Tao L, Yuan M and Yi F: Dihydromyricetin protects against diabetic
cardiomyopathy in streptozotocin-induced diabetic mice. Biomed Res
Int. 2017:3764370. 2017.
|
|
27
|
Zhang M, Wang C, Hu J, Lin J, Zhao Z, Shen
M, Gao H, Li N, Liu M, Zheng P, et al: Notch3/Akt signaling
contributes to OSM-induced protection against cardiac
ischemia/reperfusion injury. Apoptosis. 20:1150–1163. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oyagbemi AA, Omobowale TO, Ola-Davies OE,
Asenuga ER, Ajibade TO, Adejumobi OA, Afolabi JM, Ogunpolu BS,
Falayi OO, Saba AB, et al: Luteolin-mediated Kim-1/NF-kB/Nrf2
signaling pathways protects sodium fluoride-induced hypertension
and cardiovascular complications. Biofactors. 44:518–531. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baiyun R, Li S, Liu B, Lu J, Lv Y, Xu J,
Wu J, Li J, Lv Z and Zhang Z: Luteolin-mediated PI3K/AKT/Nrf2
signaling pathway ameliorates inorganic mercury-induced cardiac
injury. Ecotoxicol Environ Saf. 161:655–661. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Parker MM, Shelhamer JH, Bacharach SL,
Green MV, Natanson C, Frederick TM, Damske BA and Parrillo JE:
Profound but reversible myocardial depression in patients with
septic shock. Ann Intern Med. 100:483–490. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sato R and Nasu M: A review of
sepsis-induced cardiomyopathy. J Intensive Care. 3:482015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sagy M, Al-Qaqaa Y and Kim P: Definitions
and pathophysiology of sepsis. Curr Probl Pediatr Adolesc Health
Care. 43:260–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chousterman BG, Swirski FK and Weber GF:
Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol.
39:517–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Antonucci E, Fiaccadori E, Donadello K,
Taccone FS, Franchi F and Scolletta S: Myocardial depression in
sepsis: From pathogenesis to clinical manifestations and treatment.
J Crit Care. 29:500–511. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pathan N, Franklin JL, Eleftherohorinou H,
Wright VJ, Hemingway CA, Waddell SJ, Griffiths M, Dennis JL, Relman
DA, Harding SE and Levin M: Myocardial depressant effects of
interleukin 6 in meningococcal sepsis are regulated by p38
mitogen-activated protein kinase. Crit Care Med. 39:1692–1711.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vincent JL, Bakker J, Marecaux G,
Schandene L, Kahn RJ and Dupont E: Administration of anti-TNF
antibody improves left ventricular function in septic shock
patients. Results of a pilot study. Chest. 101:810–815. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brealey D and Singer M: Mitochondrial
dysfunction in sepsis. Curr Infect Dis Rep. 5:365–371. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Unuma K, Aki T, Funakoshi T, Hashimoto K
and Uemura K: Extrusion of mitochondrial contents from
lipopolysaccharide-stimulated cells: Involvement of autophagy.
Autophagy. 11:1520–1536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duran-Bedolla J, Montes de Oca-Sandoval
MA, Saldana-Navor V, Villalobos-Silva JA, Rodriguez MC and
Rivas-Arancibia S: Sepsis, mitochondrial failure and multiple organ
dysfunction. Clin Invest Med Med. 37:E58–E69. 2014. View Article : Google Scholar
|
|
40
|
Garrabou G, Moren C, Lopez S, Tobias E,
Cardellach F, Miro O and Casademont J: The effects of sepsis on
mitochondria. J Infect Dis. 205:392–400. 2012. View Article : Google Scholar
|
|
41
|
Neviere R, Fauvel H, Chopin C, Formstecher
P and Marchetti P: Caspase inhibition prevents cardiac dysfunction
and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care
Med. 163:218–225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Terman A and Brunk UT: Autophagy in
cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res.
68:355–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gustafsson AB and Gottlieb RA: Eat your
heart out: Role of autophagy in myocardial ischemia/reperfusion.
Autophagy. 4:416–421. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hsieh CH, Pai PY, Hsueh HW, Yuan SS and
Hsieh YC: Complete induction of autophagy is essential for
cardioprotection in sepsis. Ann Surg. 253:1190–1200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao X, Qi H, Zhou J, Xu S and Gao Y: P27
protects cardiomyocytes from sepsis via activation of autophagy and
inhibition of apoptosis. Med Sci Monit. 24:8565–8576. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang BC, Zhang CW, Wang C, Pan DF, Xu TD
and Li DY: Luteolin attenuates foam cell formation and apoptosis in
Ox-LDL-stimulated macrophages by enhancing autophagy. Cell Physiol
Biochem. 39:2065–2076. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao Z, Zhang H, Cai X, Fang W, Chai D, Wen
Y, Chen H, Chu F and Zhang Y: Luteolin promotes cell apoptosis by
inducing autophagy in hepatocellular carcinoma. Cell Physiol
Biochem. 43:1803–1812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Carling D: AMPK signalling in health and
disease. Curr Opin Cell Biol. 45:31–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Garcia D and Shaw RJ: AMPK: Mechanisms of
cellular energy sensing and restoration of metabolic balance. Mol
Cell. 66:789–800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Khan SH and Kumar R: Role of an
intrinsically disordered conformation in AMPK-mediated
phosphorylation of ULK1 and regulation of autophagy. Mol Biosyst.
8:91–96. 2012. View Article : Google Scholar
|
|
51
|
Kurumbail RG and Calabrese MF: Structure
and regulation of AMPK. Exp Suppl. 107:3–22. 2016.PubMed/NCBI
|
|
52
|
Ou HC, Pandey S, Hung MY, Huang SH, Hsu
PT, Day CH, Pai P, Viswanadha VP, Kuo WW and Huang CY: Luteolin: A
natural flavonoid enhances the survival of HUVECs against oxidative
stress by modulating AMPK/PKC pathway. Am J Chin Med. 47:541–557.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li J, Dong JZ, Ren YL, Zhu JJ, Cao JN,
Zhang J and Pan LL: Luteolin decreases atherosclerosis in LDL
receptor-deficient mice via a mechanism including decreasing
AMPK-SIRT1 signaling in macrophages. Exp Ther Med. 16:2593–2599.
2018.PubMed/NCBI
|
|
54
|
Zhang L, Han YJ, Zhang X, Wang X, Bao B,
Qu W and Liu J: Luteolin reduces obesity-associated insulin
resistance in mice by activating AMPKα1 signalling in adipose
tissue macrophages. Diabetologia. 59:2219–2228. 2016. View Article : Google Scholar : PubMed/NCBI
|
